3 days popular7 days popular1 month popular3 months popular

Archive for August 30th, 2017

PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best

Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study. The research, presented at the ESC Congress, “will change clinical practice across the world and will help improve the blood pressure and outcomes of our patients with resistant [...]

New technique to aid IVF embryo selection

Researchers at the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), led by the University of Adelaide, have successfully developed an advanced new imaging technique, which can help assess the quality of early-stage embryos. The research, reported in the journal Human Reproduction has the potential to significantly benefit the IVF industry of the future, improving [...]

The brain’s defense cells live longer than expected

Eliminating pathogens and cellular waste – this is an important task of microglia cells, the immune cells of the brain. They belong to the group of non-neural brain cells that support the normal function of nerve cells. A new study now shows that in mice these scavenger cells may live as long as the rodents [...]

16-year study suggests air temperature is external trigger for heart attack

A 16 year study in more than 280 000 patients has suggested that air temperature is an external trigger for heart attack. The findings were presented at the ESC Congress. “There is seasonal variation in the occurrence of heart attack, with incidence declining in summer and peaking in winter,” said first author Dr Moman A. [...]

How low should LDL cholesterol go?

New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to less than 10 mg/dL, safely results in additional lowering of risk of cardiovascular events. A newer class of cholesterol lowering drugs known as PCSK9 inhibitors has emerged as an effective treatment for drastically lowering LDL cholesterol beyond current treatment targets. [...]